Association of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women

被引:6
作者
Mishra, Supriya [1 ]
Gupta, Vani [1 ]
Mishra, Sameeksha [1 ]
Kulshrestha, Himani [1 ]
Kumar, Sandeep [2 ]
Gupta, Vandana [3 ]
Sachan, Rekha [4 ]
Mahdi, Abbas Ali [5 ]
机构
[1] King George Med Univ, Dept Physiol, Lucknow, Uttar Pradesh, India
[2] SGPGIMS, Dept Clin Immunol, Lucknow, Uttar Pradesh, India
[3] Uttar Pradesh Univ Med Sci, Saifai Etawah, India
[4] King George Med Univ, Dept Obstet & Gynaecol, Lucknow, Uttar Pradesh, India
[5] King George Med Univ, Dept Biochem, Lucknow, Uttar Pradesh, India
关键词
Metabolic syndrome; Obesity; Adiponectin; Acylation stimulating protein; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; OVERWEIGHT; BURDEN; ASP;
D O I
10.1016/j.dsx.2018.07.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Plasma concentrations of Acylation stimulating protein (ASP) and adiponectin are associated with body weight and energy homeostasis. The purpose of this study is to describe the potential role of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women. Methods: This is a case control study. Total 520 women were recruited for the study n = 260 women with obesity (BMI>30) study group and n = 260 women without obesity (BMI<25) control group. Serum ASP and adiponectin level were determined by enzyme linked immunosorbent assay. Results: Result indicated that WC, BP, lipid profile, FPG, FPI, IR (HOMA-IR), ASP were significantly higher but adiponectin and HDL were significantly lower in women with obesity than in women without obesity. Furthermore ASP was significantly positive correlated with WC, FPG, TG, VLDL, FPI and IR, whereas the correlation of adiponectin was significantly negative correlated with WC, FPG, TG, IR, ASP and significantly positive correlated with HDL in women with obesity. Conclusion: The study shows that high level of ASP and low level of Adiponectin could be a potential marker of women with obesity among metabolic syndrome. (C) 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:2987 / 2990
页数:4
相关论文
共 29 条
[1]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89
[2]  
Bik W, 2010, NEUROENDOCRINOL LETT, V31, P497
[3]   High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study [J].
Bo, Simona ;
Gambino, Roberto ;
Gentile, Luigi ;
Pagano, Gianfranco ;
Rosato, Rosalba ;
Saracco, Giorgio Maria ;
Cassader, Maurizio ;
Durazzo, Marilena ;
Cavallo-Perin, Paolo .
JOURNAL OF HYPERTENSION, 2009, 27 (01) :102-108
[4]  
Christian Allison H, 2009, J Cardiometab Syndr, V4, P12, DOI 10.1111/j.1559-4572.2008.00029.x
[5]   Critical review of acylation-stimulating protein physiology in humans and rodents [J].
Cianflone, K ;
Xia, ZN ;
Chen, LY .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (02) :127-143
[6]  
Ferrannini E, 1997, DIABETES METAB REV, V13, P81
[7]   The ASP and C5L2 pathway: another bridge between inflammation and metabolic homeostasis [J].
Fisette, Alexandre ;
Cianflone, Katherine .
CLINICAL LIPIDOLOGY, 2010, 5 (03) :367-377
[8]   Adipose tissue and the insulin resistance syndrome [J].
Frayn, KN .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) :375-380
[9]   COORDINATE REGULATION OF TRIACYLGLYCEROL SYNTHESIS AND GLUCOSE-TRANSPORT BY ACYLATION-STIMULATING PROTEIN [J].
GERMINARIO, R ;
SNIDERMAN, AD ;
MANUEL, S ;
LEFEBVRE, SP ;
BALDO, A ;
CIANFLONE, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (05) :574-580
[10]  
GONG D., 2003, Current Opinion in Endocrinology, Diabetes and Obesity, V10, P115